Institutional Review Board, Hospital for Special Surgery
December 04, 2009
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Aaron Daluiski, MD
Robert N. Hotchkiss, MD
Andrew J. Weiland, MD
Scott W. Wolfe, MD
Cassie Gyuricza, MD
Krystle A. Hearns, MA
This is a limited case series. As subject population will be determined via retrospective chart review, we are not actively recruiting subjects.
Data will be collected by the co-investigators through a retrospective chart review
of all patients of the principal and co investigators who had a diagnosis of distal
radius fracture and had a Volar plate removed due to pain/tenderness/or other
symptoms. Complications related to hardware removal, relief of patient
symptoms/pain, and practical instructions for surgical technique leading to easier
removal.
N/A – we are not actively recruiting subjects.
Krystle Hearns MA, Co-Director of Research, CHArm Center
hearnsk@hss.edu
212.774.7519